Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Streptococcal intertrigo: an underrecognized condition in children.

Paul J Honig1, Ilona J Frieden, Ho Jin Kim

  • 1Department of Pediatrics and Dermatology, Children's Hospital of Philadelphia and University of Pennsylvania School of Medicine, Philadelphia 19104, USA.

Pediatrics
|December 5, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Pediatric Skin Disease Frequencies and Dermatology Use by Race and Ethnicity in US Children's Hospitals.

JAMA dermatology·2026
Same author

Generative Artificial Intelligence Tools: Evaluating Ways to Automate Your SALT (GATEWAYS) Scoring of Alopecia Areata.

Pediatric dermatology·2026
Same author

Leg Length Discrepancy in Patients With Lower Extremity Cutis Marmorata Telangiectatica Congenita: A Multicenter Retrospective Study.

Pediatric dermatology·2026
Same author

Reply to "Comment on 'Digitizing Diagnoses: Distinguishing Infantile Hemangiomas From Other Vascular Anomalies'".

Pediatric dermatology·2026
Same author

Cutaneous adverse events associated with mitogen activated protein kinase inhibitors for the treatment of vascular anomalies: A dual-center retrospective study.

Journal of the American Academy of Dermatology·2025
Same author

Expanding the phenotype of CARS1 variants to include congenital hyperinsulinism.

BMC medical genomics·2025
Same journal

Video vs Telephone Consultations for Pediatric Quality of Care in Emergency Departments.

Pediatrics·2026
Same journal

A Resource to Understand and Prevent Sudden Unexpected Infant Deaths.

Pediatrics·2026
Same journal

Influenza Vaccine Effectiveness Against Pediatric Death in the United States: 2016-2025.

Pediatrics·2026
Same journal

Averting the Unthinkable: Immunization to Prevent Childhood Deaths From Influenza.

Pediatrics·2026
Same journal

Severe Postoperative Hypernatremia in an Adolescent Following Sleeve Gastrectomy.

Pediatrics·2026
Same journal

Barriers to Implementing SMART for Asthma in Pediatric Primary Care.

Pediatrics·2026
See all related articles

Group A beta-hemolytic streptococci cause childhood skin infections. A specific form, streptococcal intertrigo, affects infants and young children, presenting with redness and odor in skin folds.

Area of Science:

  • Pediatric Dermatology
  • Infectious Diseases
  • Bacteriology

Background:

  • Group A beta-hemolytic streptococci (GABHS) are common causes of childhood cutaneous infections.
  • Infants and young children may be susceptible to underrecognized forms of GABHS-related skin conditions.

Observation:

  • A specific type of streptococcal intertrigo presents with intense erythema and maceration in intertriginous areas (neck, axillae, inguinal folds).
  • Key clinical features include a distinctive foul odor and the absence of satellite lesions.
  • This presentation aids in differentiating it from other similar-appearing skin conditions.

Findings:

  • The study identifies and describes streptococcal intertrigo as a distinct clinical entity in young children.
  • Clinical features such as erythema, maceration, odor, and lack of satellite lesions are characteristic.

Related Experiment Videos

  • Differentiating this condition from mimics is crucial for appropriate management.

    • Implications:

    • Early recognition and diagnosis of streptococcal intertrigo in infants and young children are important.
    • Prompt treatment with topical or oral antibiotics, potentially with topical steroids, leads to curative outcomes.
    • Understanding this specific GABHS manifestation improves pediatric dermatological care and infectious disease management.